Literature DB >> 22406271

Crosstalk between reverse cholesterol transport and innate immunity.

Kathleen M Azzam1, Michael B Fessler.   

Abstract

Although lipid metabolism and host defense are widely considered to be very divergent disciplines, compelling evidence suggests that host cell handling of self- and microbe-derived (e.g. lipopolysaccharide, LPS) lipids may have common evolutionary roots, and that they indeed may be inseparable processes. The innate immune response and the homeostatic network controlling cellular sterol levels are now known to regulate each other reciprocally, with important implications for several common diseases, including atherosclerosis. In the present review we discuss recent discoveries that provide new insight into the bidirectional crosstalk between reverse cholesterol transport and innate immunity, and highlight the broader implications of these findings for the development of therapeutics. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406271      PMCID: PMC3338129          DOI: 10.1016/j.tem.2012.02.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  100 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.

Authors:  Patricia A Thompson; Karine C Gauthier; Alan W Varley; Richard L Kitchens
Journal:  J Lipid Res       Date:  2010-05-15       Impact factor: 5.922

3.  D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.

Authors:  Brian J Van Lenten; Alan C Wagner; Mohamad Navab; G M Anantharamaiah; Eric Ka-Wai Hui; Debi P Nayak; Alan M Fogelman
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

4.  The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.

Authors:  Lijun Dai; Geeta Datta; Zhenghao Zhang; Himanshu Gupta; Rakesh Patel; Jaideep Honavar; Sarika Modi; J Michael Wyss; Mayakonda Palgunachari; G M Anantharamaiah; C Roger White
Journal:  J Lipid Res       Date:  2010-05-22       Impact factor: 5.922

5.  TNFalpha induces ABCA1 through NF-kappaB in macrophages and in phagocytes ingesting apoptotic cells.

Authors:  Marie-Christine Gerbod-Giannone; Yankun Li; Adriaan Holleboom; Seongah Han; Li-Chung Hsu; Ira Tabas; Alan R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

6.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

7.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

8.  Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1.

Authors:  Tatyana G Vishnyakova; Alexander V Bocharov; Irina N Baranova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Thomas L Eggerman; Amy P Patterson
Journal:  J Biol Chem       Date:  2003-03-21       Impact factor: 5.157

Review 9.  Human innate immunity against African trypanosomes.

Authors:  Etienne Pays; Benoit Vanhollebeke
Journal:  Curr Opin Immunol       Date:  2009-06-24       Impact factor: 7.486

10.  Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.

Authors:  Arundhati Undurti; Ying Huang; Joseph A Lupica; Jonathan D Smith; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more
  36 in total

1.  Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.

Authors:  Shaozhuang Dong; Wenjie Ji; Shan Zeng; Jun Miao; Lifang Yan; Xinlin Liu; Junxiang Liu; Xin Zhou; Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2020-06-18       Impact factor: 4.132

Review 2.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

3.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

Review 5.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

Review 6.  MicroRNA regulation of macrophages in human pathologies.

Authors:  Yuanyuan Wei; Andreas Schober
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

7.  MicroRNA-33 Regulates the Innate Immune Response via ATP Binding Cassette Transporter-mediated Remodeling of Membrane Microdomains.

Authors:  Lihua Lai; Kathleen M Azzam; Wan-Chi Lin; Prashant Rai; Julie M Lowe; Kristin A Gabor; Jennifer H Madenspacher; Jim J Aloor; John S Parks; Anders M Näär; Michael B Fessler
Journal:  J Biol Chem       Date:  2016-07-28       Impact factor: 5.157

Review 8.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 9.  Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.

Authors:  Michael B Fessler
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 10.  Novel mechanisms of action of the biologicals in rheumatic diseases.

Authors:  Cecilia Beatrice Chighizola; Ennio Giulio Favalli; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.